CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 137 filers reported holding CYTOKINETICS INC in Q1 2019. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $18,000 | -41.9% | 1,666 | -37.5% | 0.00% | – |
| Q3 2019 | $31,000 | +3.3% | 2,666 | 0.0% | 0.00% | – |
| Q2 2019 | $30,000 | -62.0% | 2,666 | -72.4% | 0.00% | -100.0% |
| Q1 2019 | $79,000 | +27.4% | 9,666 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $62,000 | -34.7% | 9,666 | -0.5% | 0.00% | 0.0% |
| Q3 2018 | $95,000 | +239.3% | 9,717 | +144.1% | 0.00% | – |
| Q2 2018 | $28,000 | 0.0% | 3,981 | 0.0% | 0.00% | – |
| Q1 2018 | $28,000 | -12.5% | 3,981 | +1.0% | 0.00% | – |
| Q4 2017 | $32,000 | -43.9% | 3,941 | +0.6% | 0.00% | -100.0% |
| Q3 2017 | $57,000 | +54.1% | 3,918 | +26.4% | 0.00% | – |
| Q2 2017 | $37,000 | -7.5% | 3,100 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $40,000 | +66.7% | 3,100 | +55.0% | 0.00% | – |
| Q4 2016 | $24,000 | +33.3% | 2,000 | 0.0% | 0.00% | – |
| Q3 2016 | $18,000 | -5.3% | 2,000 | -2.2% | 0.00% | – |
| Q2 2016 | $19,000 | -47.2% | 2,045 | -60.2% | 0.00% | -100.0% |
| Q1 2016 | $36,000 | +89.5% | 5,135 | +176.1% | 0.00% | – |
| Q4 2015 | $19,000 | +1800.0% | 1,860 | +1020.5% | 0.00% | – |
| Q4 2013 | $1,000 | 0.0% | 166 | 0.0% | 0.00% | – |
| Q3 2013 | $1,000 | – | 166 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
| EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
| Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
| DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
| Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
| Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
| WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
| Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |